Patent · US Active

Method for administration

US11738003B2 · kind B2 · utility

0Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2020
Grant dateAug 29, 2023
Priority date—
Expiry dateFeb 19, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.